DT
RARE icon

Diversified Trust’s Ultragenyx Pharmaceutical RARE Stock Holding History

Diversified Trust’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.4M Buy
+41,966
New +$1.04M 0.02% 384
2015
Q2 		– Sell
-3,430
Closed -$213K – 485
2015
Q1 		$213K Buy
+3,430
New +$191K 0.02% 470

Other funds holding RARE

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
WC
Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return
HCA
Harbour Capital Advisors Tysons Corner, Virginia $549M AUM 54.99% 1-Year Est. Return

Diversified Trust's RARE Position: Q2 2026 in Review

Diversified Trust opened a new position in Ultragenyx Pharmaceutical (RARE) in Q2 2026: 41,966 shares worth $1.4M. The stake represents 0.02% of the portfolio and ranks #384 among its holdings. This is a return to the name: Diversified Trust previously reported a position in RARE as recently as Q1 2015.

Diversified Trust first reported a position in RARE in Q1 2015 and has held it in 2 quarters since. 21 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Diversified Trust held 41,966 shares of Ultragenyx Pharmaceutical worth $1.4M as of Q2 2026.
  • Ultragenyx Pharmaceutical was a new Diversified Trust position in Q2 2026.
  • Ultragenyx Pharmaceutical made up 0.02% of Diversified Trust's portfolio in Q2 2026, its #384 holding.
  • Diversified Trust first reported a position in Ultragenyx Pharmaceutical in Q1 2015 and has held it in 2 quarters since.
  • 21 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.